Hui Zhang Selected Research

Vaccines

2/2024	Single dose recombinant VSV based vaccine elicits robust and durable neutralizing antibody against Hantaan virus.
2/2023	The upregulation of peripheral blood polyamine metabolites spermidine and spermine in children with hand, foot, mouth disease is related to enterovirus 71 capsid protein VP1, but not VP4.
1/2023	Impacts of delta and omicron variants on inactivated SARS-CoV-2 vaccine-induced T cell responses in patients with autoimmune diseases and healthy controls.
1/2023	A tetravalent nanoparticle vaccine elicits a balanced and potent immune response against dengue viruses without inducing antibody-dependent enhancement.
1/2023	A Mosaic Nanoparticle Vaccine Elicits Potent Mucosal Immune Response with Significant Cross-Protection Activity against Multiple SARS-CoV-2 Sublineages.
1/2023	Single-cell RNA sequencing reveals the transcriptomic characteristics of peripheral blood mononuclear cells in hepatitis B vaccine non-responders.
12/2022	Endosomal Escapable and Nuclear Localizing Cationic Polyaspartate-Based CRISPR Activation System for Preventing Respiratory Virus Infection by Specifically Inducing Interferon-λ.
6/2022	Thermosensitive Hydrogels and Advances in Their Application in Disease Therapy.
1/2022	A longitudinal analysis of immune escapes from HLA-B*13-restricted T-cell responses at early stage of CRF01_AE subtype HIV-1 infection and implications for vaccine design.
1/2022	A bivalent nanoparticle vaccine exhibits potent cross-protection against the variants of SARS-CoV-2.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Hui Zhang Research Topics

Disease

922	Neoplasms (Cancer) 05/2024 - 02/2002
216	Infections 04/2024 - 08/2000
206	Inflammation (Inflammations) 05/2024 - 09/2002
137	Breast Neoplasms (Breast Cancer) 04/2024 - 03/2005
135	Neoplasm Metastasis (Metastasis) 03/2024 - 12/2004
95	Hepatocellular Carcinoma (Hepatoma) 04/2024 - 01/2003
75	Hypoxia (Hypoxemia) 04/2024 - 05/2006
75	Stomach Neoplasms (Stomach Cancer) 04/2024 - 11/2006
68	Carcinogenesis 04/2024 - 04/2003
67	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 03/2024 - 06/2004
66	Prostatic Neoplasms (Prostate Cancer) 09/2023 - 01/2005
65	Lung Neoplasms (Lung Cancer) 03/2024 - 05/2008
65	Carcinoma (Carcinomatosis) 01/2023 - 02/2002
60	Fibrosis (Cirrhosis) 05/2024 - 11/2009
60	Pain (Aches) 03/2024 - 11/2007
59	Wounds and Injuries (Trauma) 04/2024 - 01/2004
53	Colorectal Neoplasms (Colorectal Cancer) 02/2024 - 09/2005
51	Body Weight (Weight, Body) 12/2023 - 02/2005
47	COVID-19 04/2024 - 01/2020
45	Cognitive Dysfunction 05/2024 - 04/2005
45	Ovarian Neoplasms (Ovarian Cancer) 10/2023 - 07/2006
42	Pancreatic Neoplasms (Pancreatic Cancer) 01/2024 - 06/2007
40	Alzheimer Disease (Alzheimer's Disease) 05/2024 - 03/2002
38	Disease Progression 01/2024 - 07/2006
37	Adenocarcinoma 11/2023 - 09/2011
36	Stroke (Strokes) 04/2024 - 12/2005
35	Sepsis (Septicemia) 02/2024 - 12/2010
34	Atherosclerosis 08/2023 - 01/2000
33	Obesity 03/2024 - 12/2007
31	Type 2 Diabetes Mellitus (MODY) 12/2023 - 04/2009
29	Multiple Myeloma 12/2023 - 10/2010
29	Rheumatoid Arthritis 10/2023 - 02/2008
28	Glioma (Gliomas) 01/2024 - 10/2013
28	Ischemic Stroke 12/2023 - 01/2006
28	Parkinson Disease (Parkinson's Disease) 03/2023 - 03/2004
27	Osteoarthritis 02/2024 - 03/2007
27	Leukemia 01/2024 - 09/2008
27	Necrosis 12/2023 - 01/2005
27	Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia) 01/2023 - 02/2005
26	Rectal Neoplasms (Rectal Cancer) 01/2024 - 06/2014
26	Insulin Resistance 11/2023 - 05/2006
25	Liver Cirrhosis (Hepatic Cirrhosis) 01/2024 - 10/2009
25	Urinary Bladder Neoplasms (Bladder Cancer) 01/2024 - 12/2013
25	Hemorrhage 02/2023 - 08/2009
24	Myocardial Infarction 12/2024 - 11/2005
23	Cardiovascular Diseases (Cardiovascular Disease) 04/2024 - 03/2012
23	Mitochondrial Diseases (Mitochondrial Disease) 03/2024 - 01/2012
23	Ischemia 01/2022 - 12/2005
22	Osteoporosis 03/2024 - 10/2008

Drug/Important Bio-Agent (IBA)

369	Proteins (Proteins, Gene)FDA Link 04/2024 - 04/2002
214	Biomarkers (Surrogate Marker)IBA 05/2024 - 01/2005
114	MicroRNAs (MicroRNA)IBA 03/2024 - 05/2009
94	Messenger RNA (mRNA)IBA 03/2024 - 02/2003
88	CytokinesIBA 04/2024 - 09/2004
84	Long Noncoding RNAIBA 01/2024 - 01/2014
64	Therapeutic UsesIBA 05/2024 - 01/2003
61	DNA (Deoxyribonucleic Acid)IBA 05/2024 - 01/2002
58	EnzymesIBA 05/2024 - 04/2004
56	RNA (Ribonucleic Acid)IBA 04/2024 - 05/2004
56	Glycoproteins (Glycoprotein)IBA 11/2023 - 02/2006
52	Peptides (Polypeptides)IBA 05/2024 - 09/2004
52	Glucose (Dextrose)FDA LinkGeneric 01/2024 - 05/2006
50	VaccinesIBA 02/2024 - 02/2006
43	Interleukin-6 (Interleukin 6)IBA 10/2023 - 09/2004
42	LipidsIBA 01/2024 - 12/2004
39	AntigensIBA 04/2024 - 02/2002
38	LigandsIBA 02/2024 - 10/2004
36	Phosphotransferases (Kinase)IBA 04/2024 - 01/2005
36	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 09/2023 - 04/2005
35	Reactive Oxygen Species (Oxygen Radicals)IBA 04/2024 - 09/2006
35	Doxorubicin (Adriamycin)FDA LinkGeneric 04/2024 - 01/2010
35	Small Interfering RNA (siRNA)IBA 03/2024 - 02/2008
35	Anti-Bacterial Agents (Antibiotics)IBA 11/2023 - 01/2007
30	Antiviral Agents (Antivirals)IBA 03/2024 - 07/2006
29	CateninsIBA 04/2024 - 10/2011
29	CollagenIBA 01/2024 - 11/2005
28	Oxygen (Dioxygen)IBA 04/2024 - 05/2005
28	Cisplatin (Platino)FDA LinkGeneric 12/2023 - 06/2004
27	InterferonsIBA 02/2024 - 11/2005
27	AntioxidantsIBA 01/2024 - 05/2002
26	Circular RNAIBA 05/2024 - 10/2018
26	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2024 - 01/2005
26	Transcription Factors (Transcription Factor)IBA 01/2024 - 06/2007
26	ErbB Receptors (EGF Receptor)IBA 01/2023 - 12/2008
25	Immune Checkpoint InhibitorsIBA 05/2024 - 08/2017
24	LipopolysaccharidesIBA 01/2024 - 01/2009
23	AntibodiesIBA 05/2024 - 02/2002
23	Indicators and Reagents (Reagents)IBA 10/2023 - 09/2011
22	Polysaccharides (Glycans)IBA 05/2024 - 05/2006
22	Adenosine Triphosphate (ATP)IBA 04/2024 - 01/2009
22	IronIBA 03/2024 - 05/2006
22	Paclitaxel (Taxol)FDA LinkGeneric 01/2024 - 06/2004

Therapy/Procedure

418	Therapeutics 04/2024 - 01/2000
128	Drug Therapy (Chemotherapy) 04/2024 - 01/2003
71	Immunotherapy 04/2024 - 10/2004
57	Radiotherapy 03/2024 - 02/2008
39	Chinese Traditional Medicine (Traditional Chinese Medicine) 03/2024 - 11/2009
28	Ligation 01/2024 - 06/2009
25	Neoadjuvant Therapy 01/2024 - 10/2011
23	Aftercare (After-Treatment) 04/2024 - 01/2003